Publications
- Are circulating tumor cells a future weapon in the fight against castration resistant prostate cancer?Publication without faculty affiliation
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer2018 | First Faculty of Medicine, Central Library of Charles University
- Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression2017 | First Faculty of Medicine
- The characterization of four gene expression analysis in circulating tumor cells made by Multiplex-PCR from the AdnaTest kit on the lab-on-a-chip Agilent DNA 1000 platform2016 | First Faculty of Medicine
- Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest(R) System for Detection of Circulating Tumor Cells2016 | First Faculty of Medicine
- RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets?2015 | First Faculty of Medicine
- Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients2015 | First Faculty of Medicine
- Circulating tumor cells and prostate cancer prognosis2014 | First Faculty of Medicine, Third Faculty of Medicine
- Circulating Tumor Cells in Patients with Breast Cancer: Monitoring Chemotherapy Success2014 | First Faculty of Medicine, Third Faculty of Medicine
Loading network view...